| Literature identifier | Study type | Test dosage | Effective dosage | Endocrine-mediated endpoints | Systems-level perturbations |
|---|---|---|---|---|---|
| PMID:15147795 | IVR | 250 mg/kg | 250 mg/kg | Increased weights of adrenal gland | Metabolic endocrine-mediated perturbations |
| IVR | 250 mg/kg | 250 mg/kg | Increased liver weights | Hepatic endocrine-mediated perturbations | |
| IVR | 10 mg/kg | - | No significant effects observed | - | |
| IVR | 50 mg/kg | 50 mg/kg | Increased liver weights | Hepatic endocrine-mediated perturbations | |
| IVR | 2 mg/kg | - | No significant effects observed | - | |
| PMID:16472551 | IVR | 10 mg/kg/day | 10 mg/kg/day | Decreased weights of pituitary gland | Neurological endocrine-mediated perturbations |
| IVR | 10 mg/kg/day | 10 mg/kg/day | Increased liver weights in offspring | Developmental endocrine-mediated perturbations;Hepatic endocrine-mediated perturbations | |
| IVR | 10 mg/kg/day | 10 mg/kg/day | Increased weights of adrenal gland in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
| IVR | 10 mg/kg/day | 10 mg/kg/day | Decrease in T3 levels | Metabolic endocrine-mediated perturbations | |
| IVR | 10 mg/kg/day | 10 mg/kg/day | Decrease in T4 levels | Metabolic endocrine-mediated perturbations | |
| IVR | 10 mg/kg/day | 10 mg/kg/day | Increased spleen weights | Immunological endocrine-mediated perturbations | |
| IVR | 10 mg/kg/day | 10 mg/kg/day | Decreased estradiol levels in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
| IVR | 10 mg/kg/day | 10 mg/kg/day | Increased weights of adrenal gland | Metabolic endocrine-mediated perturbations | |
| IVR | 10 mg/kg/day | 10 mg/kg/day | Changes in adrenal gland morphology | Metabolic endocrine-mediated perturbations | |
| IVR | 100 mg/kg/day | 100 mg/kg/day | Decrease in T4 levels | Metabolic endocrine-mediated perturbations | |
| IVR | 10 mg/kg/day | 10 mg/kg/day | Decreased estradiol levels | Reproductive endocrine-mediated perturbations | |
| IVR | 100 mg/kg/day | 100 mg/kg/day | Decreased prostate weights | Reproductive endocrine-mediated perturbations | |
| IVR | 100 mg/kg/day | 100 mg/kg/day | Decreased testis weights | Reproductive endocrine-mediated perturbations | |
| IVR | 100 mg/kg/day | 100 mg/kg/day | Affects anogenital distance in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
| IVR | 100 mg/kg/day | 100 mg/kg/day | Decreased estradiol levels | Reproductive endocrine-mediated perturbations | |
| IVR | 100 mg/kg/day | 100 mg/kg/day | Increased weights of adrenal gland in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
| IVR | 100 mg/kg/day | 100 mg/kg/day | Increased spleen weights | Immunological endocrine-mediated perturbations | |
| IVR | 100 mg/kg/day | 100 mg/kg/day | Increased liver weights in offspring | Developmental endocrine-mediate | |
| IVR | 100 mg/kg/day | 100 mg/kg/day | Affects survival of live fetus | ||
| IVR | 1 mg/kg/day | 1 mg/kg/day | Increased androstenedione levels | ||
| IVR | 1 mg/kg/day | 1 mg/kg/day | Decrease in T3 levels | ||
| IVR | 1 mg/kg/day | 1 mg/kg/day | Increased weights of thyroid gland | ||
| IVR | 100 mg/kg/day | 100 mg/kg/day | Affects implantation | ||
| IVR | 10 mg/kg/day | 10 mg/kg/day | Affects anogenital distance in offspring | ||
| IVR | 100 mg/kg/day | 100 mg/kg/day | Reduced sperm counts | ||
| IVR | 100 mg/kg/day | 100 mg/kg/day | Decreased testosterone levels | ||
| IVR | 10 mg/kg/day | 10 mg/kg/day | Decreased ovarian weights | ||
| IVR | 10 mg/kg/day | 10 mg/kg/day | Affects implantation | ||
| IVR | 10 mg/kg/day | 10 mg/kg/day | Affects fertility | ||
| IVR | 10 mg/kg/day | 10 mg/kg/day | Affects survival of live fetus | ||
| IVR | 100 mg/kg/day | 100 mg/kg/day | Increase in TSH levels | ||
| IVR | 100 mg/kg/day | 100 mg/kg/day | Increased weights of adrenal gland | ||
| IVR | 100 mg/kg/day | 100 mg/kg/day | Decreased weights of epididymis in offspring | ||
| IVR | 100 mg/kg/day | 100 mg/kg/day | Affects fe | ||
| IVR | 100 mg/kg/day | 100 mg/kg/day | |||
| IVR | 100 mg/kg/day | 100 mg/kg/day | |||
| IVR | 100 mg/kg/day | 100 mg/kg/day | |||
| IVR | 100 mg/kg/day | 100 mg/kg/day | |||
| IVR | 100 mg/kg/day | 100 mg/kg/day | |||
| IVR | 100 mg/kg/day | 100 mg/kg/day | |||
| PMID:23125134 | IVR | 100 mg/kg | 100 mg/kg | Affects placental development | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
| IVR | 20 mg/kg | 20 mg/kg | Affects placental development | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
| IVR | 4 mg/kg | 4 mg/kg | Affects placental development | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.